Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers

Gynecologic Oncology

Volumn 133, Issue 2, 2014, Pages 283-286

  Holman, Laura L ^a   Friedman, Sue ^b   Daniels, Molly S ^a   Sun, Charlotte C ^a   Lu, Karen H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Facing Our Risk of Cancer Empowered FORCE   (United States)

Author keywords

BRCA; Delayed oophorectomy; Prophylactic salpingectomy; Risk reducing surgery

Indexed keywords

ADULT; ARTICLE; BRCA GENE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER SURGERY; CAUCASIAN; FEMALE; GENE MUTATION; HEALTH CARE COST; HEALTH SURVEY; HETEROZYGOTE; HUMAN; JEW; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENOPAUSE; ONCOGENE; OVARIECTOMY; OVARY CANCER; PATIENT ADVOCACY; PATIENT PARTICIPATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRAM ACCEPTABILITY; REFUSAL TO PARTICIPATE; RISK REDUCTION; SALPINGECTOMY; SALPINGOOOPHORECTOMY;

BRCA; DELAYED OOPHORECTOMY; PROPHYLACTIC SALPINGECTOMY; RISK-REDUCING SURGERY;

ADULT; ATTITUDE TO HEALTH; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PATIENT ACCEPTANCE OF HEALTH CARE; PREMENOPAUSE; SALPINGECTOMY; TIME FACTORS; YOUNG ADULT;

EID: 84899657911     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.02.030     Document Type: Article

References (30)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA Cancer J Clin 63 1 2013 11 30
2. J.M. Lancaster Clinical relevance of hereditary ovarian cancer K.H. Lu, Hereditary Gynecologic Cancer: Risk, Prevention, and Management 2008 Informa Healthcare New York 1 13
3. J.M. Lancaster, C.B. Powell, N.D. Kauff, I. Cass, L.M. Chen, and K.H. Lu et al. SGO committee statement: Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions Gynecol Oncol 107 2007 159 162
4. N. Howlader, A.M. Noone, M. Krapcho, N. Neyman, R. Aminou, and W. Waldron et al. SEER Cancer Statistics Review, 1975-2009 2013 National Cancer Institute Bethesda, MD [p. based on November 2011 SEER data submission]
5. National Comprehensive Cancer Network Genetic/Familial High-risk Assessment: Breast and Ovarian. NCNN Clinical Practice Guidelines in Oncology V12013 2013 NCCN Fort Washington (PA)
6. N.D. Kauff, J.M. Satagopan, M.E. Robson, L. Scheuer, M. Hensley, and C.A. Hudis et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 2002 1601 1615
7. T.R. Rebbeck, H.T. Lynch, S.L. Neuhausen, S.A. Narod, L. Van't Veer, and J.E. Garber et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 2002 1616 1622
8. N.D. Kauff, S.M. Domcheck, T.M. Friebel, M.E. Robson, J. Lee, and J.E. Garber et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study J Clin Oncol 26 2008 1331 1337
9. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, and B. Rosen et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation JAMA 296 2006 185 192
10. S.M. Domchek, T.M. Friebel, S.L. Neuhausen, T. Wagner, G. Evans, and C. Isaacs et al. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study Lancet Oncol 7 2006 223 229
11. S.M. Domchek, T.M. Friebel, C.F. Singer, D.G. Evans, H.T. Lynch, and C. Isaacs et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JAMA 304 2010 967 975
12. L.T. Shuster, B.S. Gostout, B.R. Grossardt, and W.A. Rocca Prophylactic oophorectomy in premenopausal women and long-term health Menopause Int 14 2008 111 116
13. W.A. Rocca, J.H. Bower, D.M. Maraganore, J.E. Ahlskog, B.R. Grossardt, and M. de Andrade et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause Neurology 69 2007 1074 1083
14. W.A. Rocca, B.R. Grossardt, M. de Andrade, G.D. Malkasian, and L.J. Melton III Survival patterns after oophorectomy in premenopausal women: a population-based cohort study Lancet Oncol 7 2006 821 828
15. A. Finch, K.A. Metcalfe, J.K. Chiang, L. Elit, J. McLaughlin, and C. Springate et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation Gynecol Oncol 121 2011 163 168
16. M.J. Callahan, C.P. Crum, F. Medeiros, D.W. Kindelberger, J.A. Elvin, and J.E. Garber et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction J Clin Oncol 25 2007 3985 3990
17. K. Leeper, R. Garcia, E. Swisher, B. Goff, B. Greer, and P. Paley Pathologic findings in prophylactic oophorectomy specimens in high-risk women Gynecol Oncol 87 2002 52 56
18. F. Medeiros, M.G. Muto, Y. Lee, J.A. Elvin, M.J. Callahan, and C. Feltmate et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236
19. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers Gynecol Oncol 100 2006 58 64
20. C.B. Powell, E. Kenley, L.M. Chen, B. Crawford, J. McLennan, and C. Zaloudek et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 2005 127 132
21. K.H. Lu, J.E. Garber, D.W. Cramer, W.R. Welch, J. Niloff, and D. Schrag et al. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy J Clin Oncol 18 2000 2728 2732
22. T.J. Colgan, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am J Surg Pathol 25 2001 1283 1289
23. M.S. Yates, L.A. Meyer, M.T. Deavers, M.S. Daniels, E.R. Keeler, and S.C. Mok et al. Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis Cancer Prev Res 4 2011 463 470
24. G. Chene, K. Rahimi, A.M. Mes-Masson, and D. Provencher Surgical implications of the potential new tubal pathway for ovarian carcinogenesis J Minim Invasive Gynecol 20 2 2013 153 159
25. C.K. Anderson, S. Wallace, M. Guiahi, J. Sheeder, K. Behbakht, and M.A. Spillman Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer Int J Gynecol Cancer 23 2013 417 421
26. J.S. Kwon, A. Tinker, G. Pansegrau, J. McAlpine, M. Housty, and M. McCullum et al. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers Obstet Gynecol 121 2013 14 24
27. E. Leblanc, F. Narducci, I. Farre, J.P. Peyrat, S. Taieb, and C. Adenis et al. Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ-line mutation of BRCA1 or 2 genes? Rationale and preliminary development Gynecol Oncol 121 2011 472 476
28. A.D. Findley, M.T. Siedhoff, K.A. Hobbs, J.F. Steege, E.T. Carey, and C.A. McCall et al. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial Fertil Steril 100 2013 1704 1708
29. M. Morelli, R. Venturella, R. Mocciaro, A. Di Cello, E. Rania, and D. Lico et al. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere Gynecol Oncol 129 2013 448 451
30. A. Eisen, J. Lubinski, J. Klijn, P. Moller, H.T. Lynch, and K. Offit et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study J Clin Oncol 23 2005 7491 7496